The World Health Organization (WHO) on Thursday issued an emergency use listing for the single-dose COVID-19 vaccine from China-based CanSino Biologics.
The vaccine, Convidecia, is the eleventh shot against the coronavirus to get clearance from the global health agency, whose advisory group recommended its use in people of age 18 years and above.
It was found to have 64 per cent efficacy against symptomatic disease and 92 per cent against severe COVID-19, the agency said.
Other vaccines that have similar clearance from the agency include those made by Pfizer and BioNTech, Moderna, AstraZeneca, Johnson & Johnson and Novavax.
Spanish PM Sanchez calls snap election for November 29
Hundreds of French schools stay closed ahead of nationwide day of student protests
Thousands of Imran Khan supporters start march to Pakistani capital, party says
US removes bombers from UK base at centre of suspected Iranian plot
Omani court sentences two tourists for sitting on nesting turtles
